Fig. 1The expression levels of insulin and pancreatic and duodenal homeobox 1 (Pdx1) after treatment with 30 mM glucose and 0.25 mM palmitate (A) and H2O2 (B). The expressions of insulin, Pdx1 and cyclophillin (as an internal control, Cyc) mRNAs were measured using reverse transcription-polymerase chain reaction (RT-PCR). The PCR products were resolved on a 1% agarose gel and were stained with ethidium bromide. The result shown is representative of three independent experiments. LG, 5.6 mM glucose; HG, 30 mM glucose; Pal, 0.25 mM palmitate. aP < 0.05 vs. LG. bP < 0.05 vs. 0.
Fig. 2Reactive oxygen species (ROS) generation in INS-1 cells treated with 30 mM glucose and 0.25 mM palmitate. ROS were measured as described in Materials and Methods. LG, 5.6 mM glucose; HG, 30 mM glucose; Pal, 0.25 mM palmitate; NAC, N-acetyl-L-cysteine. aP < 0.05 vs. LG, bP < 0.05 vs. HG+Pal.
Fig. 3Promoter activity assay for insulin and pancreatic and duodenal homeobox 1 (Pdx1) in INS-1 cells treated with 30 mM glucose and 0.25 mM palmitate. The promoter activities of insulin and Pdx1 were measured as described in Materials and Methods. RFU, rate fluorescence unit; LG, 5.6 mM glucose; HG, 30 mM glucose; Pal, 0.25 mM palmitate; NAC, N-acetyl-L-cysteine. aP < 0.05 vs. LG, bP < 0.05 vs. HG+Pal.
Fig. 4Pancreatic and duodenal homeobox 1 (Pdx1) protein expression and nucleo-cytoplasmic translocation of Pdx1 in INS-1 cells after treatment with 30 mM glucose and 0.25 mM palmitate. (A, B) Total proteins and nuclear proteins of Pdx1 were analyzed using Western blotting. (C) The staining of Pdx1 was performed as described in Materials and Methods. The cells were stained with anti-GFP antibody (1:100, green) to detect Pdx1 and with DAPI (blue) to detect nuclei. LG, 5.6 mM glucose; HG, 30 mM glucose; Pal, 0.25 mM palmitate; NAC, N-acetyl-L-cysteine.